Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
3.250
-0.090 (-2.69%)
At close: Mar 24, 2026, 4:00 PM EDT
3.280
+0.030 (0.92%)
After-hours: Mar 24, 2026, 7:56 PM EDT
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $167.44 million as of March 24, 2026. Its market cap has increased by 5,559.19% in one year.
Market Cap
167.44M
Enterprise Value
160.02M
1-Year Change
5,559.19%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $167.44M, an increase of 414.20%. That is a compound annual growth rate of 47.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 167.44M | 51.62% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 181.59M |
| Caribou Biosciences | 179.26M |
| NeOnc Technologies Holdings | 178.81M |
| Cartesian Therapeutics | 174.96M |
| Whitehawk Therapeutics | 172.27M |
| Protalix BioTherapeutics | 171.30M |
| Vaxart | 170.56M |
| Milestone Pharmaceuticals | 168.94M |